FDA NDC Directory · JSON-LD · Markdown

IMJUDO

NDC 0310-4535 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nametremelimumab
Labeler / ManufacturerAstraZeneca Pharmaceuticals LP
Marketing categoryBiologic License Application · App BLA761289
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsTREMELIMUMAB (300 mg/15mL)
Marketing started20221021
Package count1

External sources

Source: openFDA. Public-domain (CC0).